


rayner.com
Get leads like Rayner — and thousands more
Build targeted lists by tech stack, traffic, and more
Rayner: The British Eye Tech Titan
A 115-year-old ophthalmic giant quietly dominating the global IOL market
While Silicon Valley chases the next AI unicorn, a 115-year-old British manufacturer is quietly building a medical empire that restores vision to millions. Rayner isn't just making eye drops—they're engineering the future of sight itself.
"In a world obsessed with disruption, Rayner proves that precision engineering and 115 years of ophthalmic heritage create more lasting value than any startup hype cycle."
The Legacy Advantage
Founded in 1908, Rayner predates the internet by 81 years. Yet their digital presence shows modern sophistication. With 50% organic traffic and a global rank of #926,095, they've successfully translated century-old medical expertise into digital relevance. Their secret? They don't chase trends—they set surgical standards.
The Revenue Reality Check
Rayner's $161.9M revenue with 645 employees reveals a lean operation generating $251K per employee. Compare this to typical med-tech ratios, and you see a company that's either ruthlessly efficient or dangerously understaffed. Their 27.4K monthly visits suggest they're not competing on volume—they're dominating in surgical precision markets where conversion rates matter more than traffic.
The data reveals a fascinating paradox: Rayner's top keyword 'rayner' gets 8,940 monthly searches, yet their global rank sits at 926,095. This isn't a failure—it's a signal. They're not playing the SEO game; they're playing the surgical outcomes game. When your customers are ophthalmologists searching for 'rayner rayone 12.5d' (150 monthly searches), you don't need broad traffic—you need surgical precision in every pixel.
- Heritage meets innovation: 115 years of ophthalmic excellence with cutting-edge IOL technology
- Surgical precision over scale: $251K revenue per employee indicates focused, high-value operations
- Digital maturity: 50% organic traffic shows they understand modern B2B medical procurement
- Global reach with British roots: Operating across continents while maintaining UK manufacturing heritage
The Visionary's Edge
Rayner proves that in medical tech, heritage isn't a legacy burden—it's a competitive moat that no startup can replicate overnight.
What tech stack does Rayner use?
How much traffic does Rayner get?
Traffic & Engagement
Traffic Sources
Where is Rayner's audience located?
What keywords does Rayner rank for?
5 keywordsHow is Rayner's SEO?
Open Graph Image

https://rayner.com/global/wp-content/uploads/sites/21/2022/07/IMG_5642-scaled.jpg
Meta Tags
Ophthalmic Solutions: IOLs and Eye Drops | Rayner Global
Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) & eye drops to support ocular health.
H1 Tags
Schema Types
What is Rayner's revenue?
Who works at Rayner?
Loading leads...
What do customers think of Rayner?

Rayner
Categories
Activity & Engagement
Contact Information
Reviews (2)
Prescribed by GP for hay fever awful…
Prescribed by GP for hay fever awful system scratched my eye with sharp plastic where you have to snap it off. Definitely not appropriate especially for older people .
Defective product and lack of support
After a cataract diagnosis requiring intraocular lens (IOL) implantation, I underwent surgeries in the end of 2018 on both eyes for the implantation of Rayner RayOne trifocal IOLs. Shortly after, I felt some discomfort in my right eye, but I understood that this was natural due to the adjustment of the trifocal lenses over time. However, the discomfort did not improve, and in early 2022, my vision in my right eye began to blur, progressively worsening to the point of having difficulty in driving, reading, watching TV or using a computer, along with severe headaches, dizziness, and balance problems. I consulted three different doctors to obtain independent diagnoses of the cause of the blurred vision. Since there were no post-surgical problems with my left eye, a defective lens in my right eye was suspected. After a series of tests, this suspicion was confirmed by my ophthalmologist and I would have to undergo risky surgery, with the possibility of vision loss, to remove the defective Rayner trifocal lens. Before undergoing surgery, however, I repeatedly tried to contact Rayner representatives in Brazil (Adapt Ltda) to clarify the correct procedure to be adopted in this case, but unfortunately I received no response. This led me to send an email to Rayner in the UK detailing my concerns and questions. Rayner UK's response offered no guidance or support for my problem, stating that the company could not comment on individual cases or provide medical advice directly to the public. They only referred me to an article addressing "Intraocular Lens Opacification" suggesting that the calcification of my right lens may have been caused by diabetes or chemotherapy, but I never had such health conditions. Furthermore, in cases of health issues, both the left and right lenses should become opaque, not only one. In June 2023, I underwent surgery to remove the defective Rayner IOL. The surgery, paid for by me and without any support from Adapt or Rayner, was successful (even though the doctor was not able to remove completely the defective lens and part of it still remains on my right eye). Subsequently, the Rayner company, which had been missing until then, contacted my ophthalmologist requesting my authorization for the collection and investigation of the cause of the lens opacification. I agreed to lend my lens, imagining that I would get answers to my problem. The defective Rayner lens was collected in July 2023 by an Adapt employee. Two months later, in September 2023, having received no news about the analysis of my lens, I contacted Rayner UK by email. Rayner mentioned that the lens was still in Brazil and that the analyses on the defective lens would be carried out in a third-party laboratory in the UK, as Rayner did not have the capacity to perform such analyses on the lens. Additionally, contrary to what we had agreed before, they informed me that the analyses would not attempt to pinpoint the cause of the lens opacification, meaning they would not provide the reason for the lens opacification. Had I known that Rayner would not attempt to find out the reason of opacification, I would not have wasted my time sending the defective lens to them. Therefore, I requested Rayner to immediately return the lens, as I had decided to arrange a laboratory myself to find out the reason for the Rayner lens opacification. Rayner completely ignored my request. It was only 4 months later, in November 2023, that Rayner UK responded to me saying that the lens would only be returned upon the request of the clinic which implanted the defective lens in my eye in 2018. According to them, I am not the owner of the lens, although I had paid for it, I had it implanted and extracted from my eye, and I had authorized it to be sent to Rayner for analysis. Also in November 2023, my ophthalmologist received the results of the analysis of the lens opacification, indicating that "the cause cannot be established from the evidence and information available." Since the reports, written by Rayner themselves, will never determine the cause of the opacification (or any problems you may have), they will never be responsible for any problems you may have with their lenses. In short, my experience with Rayner's product and support was deeply disappointing. I have faced significant health (until now) and financial implications to a Rayner defective lens, and I expected more transparency and genuine efforts to promptly and effectively address the problem. The lens is still in Rayner's possession, and I have given up on retrieving it, realizing it would be impossible. If you intend to use Rayner IOL lenses, please bear in mind that no support will be provided to you in the event of a defective product. If you still decide to use a Rayner lens, I wish you good luck.
Frequently Asked Questions about Rayner
What is Rayner's Revenue?
What does Rayner do?
How fast is Rayner growing?
What technologies does Rayner use?
Who are Rayner's competitors?
What do customers think of Rayner?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Rayner?
Contact Information
Export rayner.com Data
Download the complete tech stack, analytics, leads, and company data for rayner.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About rayner.com
Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) & eye drops to support ocular health.
Company Overview
rayner.com Social Media
Contact rayner.com
Email Addresses
Phone Numbers
Technology Stack
rayner.com uses 22 technologies across their website including AccessiBe, Google Maps, Font Awesome, Adobe Fonts, and more.
Accessibility
AccessiBe
Maps
Google Maps
Fonts
Font Awesome, Adobe Fonts
Security
reCAPTCHA
Programming Languages
PHP
CMS
WordPress
Traffic & Audience
rayner.com receives approximately 27.4K monthly visitors and ranks #926,095 globally. The website has a bounce rate of 36% with visitors viewing an average of 2.6 pages per visit. Users spend an average of 0:32 on the site.
The majority of rayner.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is rayner.com?
What technologies does rayner.com use?
How do I contact rayner.com?
What are rayner.com's social media accounts?
Is rayner.com hiring?
How popular is rayner.com?
Related Searches
This page provides publicly available information about rayner.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit rayner.com directly at https://rayner.com.